The practical use of AFP is complex and suboptimal due to varying recommendations on the upper limit of normal (ULN) with associated variability in sensitivity and specificity depending on the ULN applied [11] which may vary between aetiologies of the underlying liver disease, ethnicity and sex [13, 17–19]. The gene discussed is AFP; the disease is liver disorder.